ATE478964T1 - Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde - Google Patents

Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Info

Publication number
ATE478964T1
ATE478964T1 AT05745933T AT05745933T ATE478964T1 AT E478964 T1 ATE478964 T1 AT E478964T1 AT 05745933 T AT05745933 T AT 05745933T AT 05745933 T AT05745933 T AT 05745933T AT E478964 T1 ATE478964 T1 AT E478964T1
Authority
AT
Austria
Prior art keywords
probe
screening
diagnosing
nucleic acid
marfan syndrome
Prior art date
Application number
AT05745933T
Other languages
English (en)
Inventor
Norio Niikawa
Naomichi Matsumoto
Catherine Boileau
Gwenaielle Beroud
Guillaume Jondeau
Original Assignee
Univ Nagasaki
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nagasaki, Inst Nat Sante Rech Med filed Critical Univ Nagasaki
Application granted granted Critical
Publication of ATE478964T1 publication Critical patent/ATE478964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Testing Of Individual Semiconductor Devices (AREA)
  • Techniques For Improving Reliability Of Storages (AREA)
AT05745933T 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde ATE478964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004158099A JP4706193B2 (ja) 2004-05-27 2004-05-27 マルファン症候群の分析のためのプローブの使用、スクリーニング方法およびキット
PCT/JP2005/010213 WO2005116253A1 (ja) 2004-05-27 2005-05-27 マルファン症候群診断用プローブ、及び当該プローブを用いたスクリーニング法

Publications (1)

Publication Number Publication Date
ATE478964T1 true ATE478964T1 (de) 2010-09-15

Family

ID=35450905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05745933T ATE478964T1 (de) 2004-05-27 2005-05-27 Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Country Status (6)

Country Link
US (2) US20080199856A1 (de)
EP (1) EP1767653B1 (de)
JP (1) JP4706193B2 (de)
AT (1) ATE478964T1 (de)
DE (1) DE602005023160D1 (de)
WO (1) WO2005116253A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018160987A1 (en) * 2017-03-02 2018-09-07 The Johns Hopkins University Map kinase pathway targets for the treatment of marfan syndrome
WO2019113123A1 (en) * 2017-12-04 2019-06-13 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
CN109666676A (zh) * 2019-01-29 2019-04-23 四川省人民医院 筛查马凡综合征的试剂盒
CN109666729A (zh) * 2019-01-29 2019-04-23 四川省人民医院 一种马凡综合征筛查试剂盒
CN109666678A (zh) * 2019-01-29 2019-04-23 四川省人民医院 检测马凡综合征的试剂盒
CN114214398B (zh) * 2021-09-26 2022-10-25 百世诺(北京)医学检验实验室有限公司 突变的fbn1基因及马凡氏综合征检测试剂盒
CN114107452B (zh) * 2021-12-07 2022-06-24 深圳市眼科医院 一种基于fbn1基因插入突变的马凡综合征检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008011A (en) * 1991-10-31 1999-12-28 Whitehead Institute For Biomedical Research TGF-β type II receptor cDNAs
CA2122491A1 (en) * 1991-10-31 1993-05-13 Herbert Y. Lin Tgf-.beta. type receptor cdnas and uses therefor

Also Published As

Publication number Publication date
WO2005116253A1 (ja) 2005-12-08
JP4706193B2 (ja) 2011-06-22
US20080199856A1 (en) 2008-08-21
EP1767653A4 (de) 2008-04-16
DE602005023160D1 (de) 2010-10-07
EP1767653A1 (de) 2007-03-28
EP1767653B1 (de) 2010-08-25
US20100209923A1 (en) 2010-08-19
JP2005333896A (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
ATE545712T1 (de) Verfahren mit verwendung von poren
ATE550099T1 (de) Verbessertes system für mehrfarbige echtzeit-pcr
ATE488251T1 (de) Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
ATE450623T1 (de) Modifikatoren der lichtemission und ihre verwendungen zur detektion, amplifikation und analyse von nukleinsäuren
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
ATE474938T1 (de) Verfahren zur erhöhung der genauigkeit einer nukleinsäuresequenzierung
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
NO20070521L (no) Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE478964T1 (de) Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde
DE60326153D1 (de) Verfahren zur diagnose von morbus alzheimer
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
BRPI0309792A2 (pt) método para prevenção de incrustação em solução básica inibindo polimerização e solubilizando depósitos usando lactamas ou aminoácidos
DE60041582D1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
DE50207820D1 (de) Verfahren zum nachweis von hybridisierungsereignissen in nukleinsäuren
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE530548T1 (de) Neue dibenzoäc,hüä1,5ü naphthyridine und ihre verwendung als dna-sonden
DE60330779D1 (de) Für alkalische a-galactosidasen codierende polynukleotidsequenzen und verfahren zur verwendung davon
ATE544852T1 (de) Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties